The Week In... Medical Devices (18-22/11)
  • Posted on: 22/11/2019
  • Category: Industry

The Week In... Medical Devices (18-22/11)

New study says older diabetes patients would benefit from wearing glucose monitors, Baring Private Equity Asia to buy Lumenis, over half of UK SMEs ‘unprepared’ for Brexit despite further delay, and UK AI company receives FDA clearance. 

Interested in Star’s innovative outsourcing and resourcing solutions? 

Contact Operations Director, Mark Ward, on 07872 105 540 or email mark.ward@starmedical.co.uk.

On the hunt for a new role, or just curious? 

Visit our candidate page, submit your CV to candidates@starmedical.co.uk, or give our offices a ring! 

Over half of UK’s SMEs are unprepared for Brexit despite another missed exit date

Over half (54%) of the UK’s SMEs, equating to 3.1[1] million businesses, admit they had not prepared in any way for Brexit ahead of the 31 October deadline according to the latest Q3 SME Confidence Tracker from Bibby Financial Services.

Wearable monitors help older people better manage diabetes – study

Older people with diabetes would benefit from using wearable glucose monitors – according to new research from the University of East Anglia.

Baring Private Equity Asia to buy medical device maker Lumenis

Baring Private Equity Asia has agreed to acquire Lumenis from London-based investment firm XIO Group in a deal that values the Israeli medical device maker at more than $1 billion.

Sensyne Health names partners for digital health software sale in US

UK-based clinical artificial intelligence (AI) technology company Sensyne Health has named Cognizant and Agorai as its partners for the launch and commercialisation of its digital health software products in the US.

UK AI player receives FDA clearance for image analysis system

Ultromics has received 510(K) clearance from the U.S. Food and Drug Administration (FDA) for its image analysis system, EchoGo Core. 


While you’re here…

…and are interested in our content, why not sign up to our newsletter? It’s just below here.